Results 41 to 50 of about 333,767 (280)

Assessing D‐Squame as a Minimally Invasive Technique to Evaluate the Cutaneous Immune Response mRNA in a Dog Model of Canine Atopic Dermatitis

open access: yesVeterinary Dermatology, EarlyView.
ABSTRACT Background Canine atopic dermatitis (cAD) is a multifactorial, inherited skin disease, estimated to affect ≤ 15% of dogs. Studies of skin messenger mRNA in cAD currently use invasive methods, including blood sampling and biopsy collection, whilst advances in human atopic dermatitis study methodology have demonstrated reliable use of minimally ...
Xavier Langon   +5 more
wiley   +1 more source

Repercussão das Colheitas de Sangue sobre os Valores de Hemoglobina em Recém-Nascidos de Muito Baixo Peso (RNMBP) Submetidos a Terapia Intensiva [PDF]

open access: yes, 1995
A perda iatrogénica de sangue constitui um problema comum nas unidades de cuidados intensivos neonatais. O objectivo deste trabalho foi quantificaras espoliações de sangue para estudos analíticos em 22 RNMBP durante as primeiras três semanas de ...
Clington, A   +4 more
core  

Signal to cut-off (S/CO) ratio and detection of HCV genotype 1 by real-time PCR one-step method: is there any direct relationship?

open access: yesBrazilian Journal of Infectious Diseases
BACKGROUND: Polymerase chain reaction (PCR) methods play an essential role in providing data related to diagnosis, monitoring and treatment of hepatitis C virus (HCV) infection.
Guilherme Albertoni   +4 more
doaj   +1 more source

Sangue Dourado

open access: yesSimbiótica. Revista Eletrônica, 2023
Poema
openaire   +1 more source

Protection of fundamental human rights by improving patient access to plasma‐derived therapies and donor health protection

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives The main use of plasma has evolved into market‐driven plasma‐derived medicinal products (PDMPs), but it still requires donors. Availability of PDMPs in access to care is often considered restrictively, in terms of volumes of plasma required for production and whether or not to remunerate donors.
Jean‐Baptiste Thibert   +7 more
wiley   +1 more source

IMPLEMENTAÇÃO DO PROGRAMA DE LAVAGEM DE MÃOS NO SERVIÇO DE HEMOTERAPIA PARA MELHORIA DA SEGURANÇA DO PACIENTE/DOADOR/COLABORADOR

open access: yesHematology, Transfusion and Cell Therapy, 2023
Objetivo: Promover a adesão dos colaboradores ao processo de lavagem de mãos, a partir da realização de uma dinâmica estabelecida, visando a melhoria na segurança do ciclo do sangue.
NMO Godinho   +4 more
doaj   +1 more source

SANGUE NEGRO

open access: yesRevista Água Viva, 2021
Poema de denúncia.
openaire   +1 more source

International multicentre evaluation of a new anti‐idiotypic anti‐daratumumab for resolving pre‐transfusion interferences

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Daratumumab, a therapeutic human anti‐CD38 monoclonal antibody, improves multiple myeloma outcomes but interferes with pre‐transfusion testing by binding CD38 on reagent red blood cells (RBCs), potentially masking clinically significant alloantibodies.
Arnaud Reggiani   +30 more
wiley   +1 more source

Erythrocytometry and seric proteinogram of umbilical cord and jugular of foals at birth and respective mothers [PDF]

open access: yes, 2007
Colheram-se amostras de sangue do cordão umbilical (SCU) e do sangue circulante de cinco eqüinos neonatos, imediatamente após o nascimento, e o sangue da própria mãe, utilizando-se um sistema a vácuo.
Campos Filho, Euclides   +3 more
core   +1 more source

Molecular characterization of D variants in Brazilian blood donors and their association with RhCE and Duffy phenotypes

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Serological classification of RhD‐negative and weak D is often insufficient in admixed populations, where diverse RHD variants have clinical implications. In Brazil's highly admixed population, RhD interpretation and donor–recipient matching are particularly challenging.
Thamy C. S. Silva   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy